Pharmacy Benefit Management Institute Prescription Drug Benefit Cost and Plan Design Online Report 2008-09 Edition Search
Tables/FiguresGlossaryResources
Executive Summary Methodology Profile of Respondents Plan Design Features Cost Sharing Highlights Pharmacy Reimbursement Highlights Drug Cost Highlights Utilization Management Highlights Home
Prescription Drug Benefit Cost and Plan Design Report
 
Sponsored by Takeda

Plan Design Features

Effective drug benefit plan designs address a myriad of variables in addition to how much is paid for each prescription. These variables are discussed below.

Formulary
A formulary is a list of drugs covered by a prescription drug plan. The survey question about formulary structure reflects the range of formulary options prevalent in the marketplace. This year 89% of respondents using a formulary have it structured with multiple tiers as shown in Figure 3. Closed formularies have almost disappeared, replaced by formularies with multiple tiers that require members to pay more for more expensive drugs instead of limiting access to therapies. Closed formularies do not cover drugs not included on the drug list.

Mail-service Pharmacy
A total of 93.7% of employers offer access to mail-service pharmacy to supply maintenance medications used to treat chronic conditions. Only 12.4% of employers require maintenance medications to be dispensed by a mail-service pharmacy, commonly referred to as “mandatory mail”. There is little change in mail-order strategy since 2007. Less than a third, or 31.4%, of employers use retail pharmacies to dispense maintenance supplies of medication. For a second year, 60% of employers using retail pharmacies to dispense maintenance supplies are not restricting dispensing to select pharmacies.

Transparency
About half, or 52.3%, of employers perceive the nature of the financial relationship with their PBM to be transparent, which is a modest increase over 2007 data. A total of 13.1% of employers did not know if their PBM financial relationship was transparent. This survey question addresses the employer’s perception of transparency; it does not capture any pricing information.

Benefit Limits
Drug-specific annual deductibles, maximum annual benefits, or out-of-pocket limits are not included in the majority of employers’ plan designs. When used, the most commonly adopted features are a drug-specific annual deductible used by 17.6% of employers and a drug-specific out-of-pocket limit used by 14.6% of employers. Only 3.5% of employers have a drug-specific maximum annual benefit.

  • The median drug-specific annual deductible is $50 for single and $105 for family. A deductible is the amount a plan member pays before the plan pays for prescriptions.
  • Median drug-specific out-of-pocket limit is $1,500 for single and $2,800 for family. An out-of-pocket limit is the total amount a member must pay for prescription drugs in a 12-month period.
  • Median maximum annual benefit for drugs is $5,000 for single and $9,000 for family. A maximum annual benefit is the total amount a plan will pay for prescription drugs in a 12-month period.

Consumerism
Only five employers responding to the survey have a consumer-directed health plan, with a high dollar deductible for specific drugs. This does not represent an increase in these types of drug plans since 2007.

Specialty Pharmacy
While 73.9% of employers offer a specialty pharmacy benefit, a detailed review of the cost sharing data supplied by employers indicates that specialty cost share amounts typically fall under the preferred or nonpreferred brand amounts. There do not appear to be any major changes in distribution channel management since 2007 as shown in Table 9.

Retiree Coverage
Almost half, or 47.2%, of employers are providing retiree drug coverage. The retiree drug subsidy program is the strategy of choice for 63% of the employers with retiree coverage as illustrated in Table 10. Nearly a third, or 31.5%, offer group coverage through a Prescription Drug Plan. The difference in retiree coverage options for 2008 is most likely to represent the choices of the larger group sizes responding as opposed to any significant strategy shift in the marketplace.New Medicare legislation may expand the number of Part D covered drugs, as discussed in the Executive Summary.

Tables
9 Dispensing Arrangements for Specialty Pharmacy Benefit
10 Strategies for Coordinating with Medicare Part D

Figures

3 Type of Formulary Used by Employers